TechJournal South
Header

Posts Tagged ‘People’

GoDaddy goes for $2.25B; Zynga files for IPO, BLiNQ

Tuesday, July 5th, 2011

Go DaddyGo Daddy Group Inc., parent of domain registrar GoDaddy.com, has sold to private equity firms for $2.25 billion, the company said. The company sold to KKR, Silver Lake and Technology Crossover Ventures.

GoDaddy is looking to exceed $1.1 billion in revenue this year. The company is known for its excellent company service. If you ever bought a domain name from GoDaddy, you likely got a call not long after from one of its service people. The company, based in Scottsdale, AZ, was founded by CEO Bob Parsons in 1997.

Some folks in the tech community have expressed concerns that the private equity buyers of the company will milk it for all its worth without regard to its tradition of selling domain names inexpensively with great service. We’ll see.

Zynga, Farmville-maker files for $1 billion IPO

San Francisco-based Zynga, the game maker that created Farmville and Mafia Wars, two of the most popular Facebook games, has filed with the U.S. Securities and Exchange Commission for an initial public offering of stock to raise at least $1 billion.

For a detailed infographic on Zynga’s path from founding to IPO see: Zynga infographic at Namesake.com.

Zynga, founded four years ago, has users in 166 countries. About 230 million people play its games every month. The company has revenue of $597 million in 2010, up from $121 million in 2009. The profitable company earned $90.6 million in 2010.

It is the latest of the much ballyhooed Internet companies to seek public status following LinkedIn (Linkd) Corp. Analysts expect even greater interest in Zynga’s IPO and the amount of money it decides to raise may change as the level of that interest is better evaluated.

The company was founded by CEO Mark Pincus and has about 2,300 employees. The company’s shares recently sold for $15 each on secondary markets, which would value the firm at $12.6 billion.

The filing with the SEC reveals the company is investing in its own data centers to supplement its use of the Amazon cloud service, which allowed the company to grow fast without building infrastructure. Most Facebook game companies rely on Amazon’s cloud. VentureBeat says Zynga’s ability to design apps that take advantage of Amazon’s cloud is one reason for its success.

Despite the inevitable suggestions that the moonbeam valuations of Internet companies may signal another Internet bubble, many analysts point out that the difference is in the fact the today the Internet is more fully integrated into our public, personal and professional lives. These companies have substantial revenues, enormous numbers of users, and some, such as Zynga are even profitable.

Some analysts note, though, that their market values may still be quite overvalued.

BLiNQ names John Tawadros president, COO

BLiNQ Media, a global technology innovator in Facebook advertising and the only pure-play media and technology company worldwide with official access to the Facebook Ads API,  has hired former COO for top search-marketing firm iProspect John Tawadros as president and COO.

Prior to joining BLiNQ Media, Tawadros was the COO of iProspect. Over the course of ten years he helped build the company from a basement startup to the #1 search marketing firm in the world, acquired for $50MM in 2004.

While at iProspect, he built and ran a world-class client services team with a 90%+ client retention rate, a companywide training program and scalable business processes to drive efficiencies, communications, ROI and overall performance.

The client-facing, algorithmic and paid search, technology, training and innovation teams all reported to Tawadros. He also played a significant role in the integration of iProspect with Aegis and in the acquisition and integration of a Texas-based retail industry search firm.

“Social media is the new search,” said Tawadros. “Facebook, the biggest player in digital media, is now the home of innovation, and BLiNQ Media helps advertisers make the most of it. It’s an honor to join this creative, intelligent and hard-working team.”

 

NC-based TransS1 names Ken Reali CEO

Wednesday, January 5th, 2011

TransS1WILMINGTON, N.C., – TranS1 Inc. (Nasdaq:TSON)  has appointed current President and COO, Ken Reali, as CEO of the company. Rick Randall, its current CEO, will continue to serve as a member of the board in the newly created position of Executive Chairman.

TranS1 is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region.

Reali has over 20 years of general management, sales and marketing experience with leading medical device and orthopedic companies.  Reali joined the Company from Smith & Nephew where he spent five years in various senior marketing, sales and product development positions.

Reali held senior marketing, sales and product development positions at Stryker for seven years. Prior to joining Stryker, he worked as a territory and product manager at Biomet for eight years.

Atlanta’s Celtaxsys names Dr. Michael Hanley CEO, chairman

Friday, December 3rd, 2010

Dr. Michael Hanley

Dr. Michael Hanley

ATLANTA – Celtaxas Inc., a Georgia-based drug discovery start-up, has named Dr. Michael Hanley CEO and chairman.

Dr. Hanley has served on both the Scientific Advisory Board and Board of Directors of Celtaxsys since 2007. Celtaxas is focused on discovery and development of therapeutics to treat inflammation via “immunoregulators” that help activate and aim immune cells.

It’s a real plus for a drug discovery start-up to have someone with Dr. Hanley’s experience in founding start-ups and in managing drug discovery. The life sciences field is so regulated that experience can make all the difference in whether a company stays focused and develops treatments that can weather the arduous US Food and Drug Administration approval process without costly sidetracks and delays.

Dr. Hanley brings more than 20 years of managerial experience in the international life science industry including drug discovery, product development, and production. He was most recently the Chief Scientific Officer for Amylin Pharmaceuticals where he was responsible for discovery research and preclinical development.

From 1981 to 1997, Dr. Hanley held faculty positions at Imperial College, London, the Medical Research Council Laboratories, Cambridge, and the University of California at Davis, where he was Professor of Biological Chemistry. From 1997 to 2003, he was a senior consultant for healthcare investors in the venture capital and banking communities and for biotechnology companies such as Cell Therapeutics, Zymogenetics, Elan Pharmaceuticals, and Chiron.

Dr. Hanley has founded several start-ups, such as Resolvyx Pharmaceuticals and Psylin Neurosciences, and is currently on boards of Aileron Therapeutics, Metabolic Solutions Development Company, Isogenica, and Pieris. He received a bachelor’s degree in Biochemistry and a Ph.D. in Molecular Biology from the University of California, Berkeley.

TJS Editor/writer Allan Maurer: Email Allan at TechJournalSouth dot com.

Vanda Pharmaceuitcals nabs former Surgeon General for board

Thursday, July 1st, 2010

VandaROCKVILLE, MD – Vanda Pharmaceuticals Inc. (Nasdaq:VINDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders, says former acting U.S. Surgeon General Steven Galson to its board.

Mihael H. Polymeropoulos, M.D., president and CEO of Vanda, said, “Dr. Galson’s experience as the former Acting U.S. Surgeon General and Deputy Director and Director of the Center for Drug Evaluation and Research will add tremendous value to the board.”

We don’t generally note board appointments, but nabbing a former Surgeon General–even an acting one–is something of a coup.

Currently, Dr. Galson is the Senior Vice President for the Civilian Health Operation at Science Applications International Corporation (SAIC). He has also held executive positions in the U.S. Environmental Protection Agency, U.S. Department of Energy, and the Centers for Disease Control and Prevention’s National Institute for Occupational Safety and Health.

That sort of background has to be a plus for any company in the highly regulated pharmaceutical industry.

OpGen names C. Douglas White CEO

Wednesday, June 30th, 2010

 

Douglas White

C. Douglas While, OpGen CEO

GAITHERSBURG, MD – OpGen, Inc., a genomics solutions company, has named C. Douglas White CEO. He replaces Evan Jones, managing member of jVen Capital and previous co-founder, chairman and CEO of Digene Corporation, who held the position on an interim basis.

In conjunction with this appointment, Jones remains a member of OpGen’s board of directors, and White also joins the board.

White brings more than two decades of global leadership experience in clinical diagnostics, including senior executive roles with BG Medicine, QIAGEN, Digene, Bayer Diagnostics and Chiron Diagnostics.

Jones commented, “Doug was an integral part of our success at Digene, guiding strategy and maximizing the value of the company’s technology, and I am confident that his considerable experience will provide invaluable insights as we seek to maximize the potential of OpGen’s Optical Mapping technology.”

Prior to joining OpGen, Mr. White served as executive vice president and general manager for the diagnostics division of BG Medicine, a commercial-stage company focused on the discovery and application of novel biomarkers associated with cardiovascular disease, central nervous system and autoimmune disorders.

White served as chair of the Americas Management Council and senior vice president of sales and marketing, Americas, for QIAGEN, N.V. He also served as senior vice president commercial operations, Americas and Asia Pacific, for Digene Corporation, prior to the company’s $1.6 billion acquisition by QIAGEN in July 2007.

Online Resources names Cowan president, CEO

Tuesday, June 15th, 2010

Online ResourcesCHANTILLY, VA – Online Resources Corp. (Nasdaq: ORCC), a provider of online financial services, has named Joseph L. Cowan president and CEO.

He succeeds interim CEO John C. Dorman, who will continue as chair of the company’s board.

Cowan brings to Online Resources a proven track record in executive management in technology companies, including significant experience in repositioning companies for sustainable growth. Most recently, he served as chief executive officer of publicly owned Interwoven, an enterprise content management software company. At Interwoven,  Cowan achieved record financial performance, growing revenue from $200 million to $260 million and operating profit margins from 11 percent to 19 percent over a two-year period.

Prior to Interwoven,  Cowan was chief executive officer of Manugistics Group, a publicly owned supply chain management software company.

Cowan also served as president and chief executive officer of EXE Technologies, and in management positions at Invensys, Wonderware, Texas Instruments, Eurotherm Corp. and Monsanto.

Online Resources powers financial interactions between millions of consumers and the Company’s financial institution and biller clients.

NC-based InterAct Public Safety Systems names new CEO

Tuesday, June 8th, 2010

InteractWINSTON-SALEM, NC - Interact Public Safety Systems, which sells safety and security software to government agencies and commercial clients, has named John McNulty CEO.

Andrew J. “Flip” Filipowski remains as executive chair.

McNulty brings over 40 years of success in the technology industry having held leadership positions including general manager, senior vp, president, CEO and chair of companies in the software, semi-conductor, hardware, networking, and communications industries.

Most recently, for the nine years from mid 1999 to 2008, he served as chair, president and CEO of Secure Computing Corporation, a NASDAQ company acquired in November 2008 by McAfee Corp.

InterAct provides integrated multi-agency, multi-jurisdictional public safety and homeland security systems technology.

The InterAct Connections Framework is a platform upon which customized comprehensive public safety solutions are built and presently used by more than 2,000 government agencies and private enterprises globally. The company’s telephony, computer aided dispatch/mapping, mobile data sharing, and records management systems deliver emergency responders vital information they need.

Florida-based AxoGen names new CEO

Monday, May 17th, 2010

karenzaderej

Karen Zaderej, new CEO at AxoGen

ALACHUA, FL – AxoGen Inc., a company developing new and more effective products to treat peripheral nerve damage has promoted Karen Zaderej to CEO.

Zaderej was formerly the Chief Operating Officer. Former AxoGen CEO, Jamie Grooms has retained the role of chairman of the Board for AxoGen.

We reported that the company, previously one of TechJournal Souths 50 Companies to watch, raised $3.6 milllion of a financing round targeted at $4.7 million in January. The company previously raised about $20 million from Accuitive Medical Ventures, Cardinal Partners, DeNovo Ventures and Springboard Capital II, SynoGen and the Emergent Growth Fund and with debt financing from Oxford Fiance Corp.

The company says Zaderej has been instrumental in the successful development and launch of the AxoGen portfolio of nerve products for bridging, connecting and protecting peripheral nerves.

Zaderej has more than 20 years of experience in the medical device and tissue markets. At Ethicon, a Johnson & Johnson company, she held senior positions in Marketing, Business Development, and R&D as well as ran a manufacturing business. After leaving J&J, she started Zaderej Medical Consulting to assist medical device companies build and execute winning commercialization plans.

With licensed technologies from the University of Florida, the University of Texas, and Emory University, researchers at AxoGen have developed an innovative technology platform making it possible to process allograft nerves while preserving the relevant characteristics of the three dimensional scaffold of the nerve tissue.

Chimerix names new chair, president and CEO

Tuesday, May 4th, 2010

chimerixresearchersRESEARCH TRIANGLE PARK, NC - Chimerix Inc., a biotechnology companydeveloping orally-available antiviral therapeutics, has named Kenneth I. Moch  president and CEO.

Moch joined Chimerix as Chief Operating Officer in July 2009, bringing more than 25 years of experience in creating, managing and financing biomedical companies. Moch will also join the company’s board.

Moch has played an integral role in building several life science companies, having previously led Alteon Inc. and Biocyte Corporation as Chief Executive Officer. He also served as managing director, Healthcare Banking at ThinkEquity Partners.

Moch was a co-founderand vice president of The Liposome Company Inc. (acquired by Elan).

George Painter, Ph.D., Chimerix’s former president and CEO, has been named Chief Scientific Officer and chairman of the company’s board.

Painter will oversee Chimerix’s drug discovery and development efforts and seek opportunities to leverage the company’s proprietary platform capabilities and antiviral expertise in the advancement of important new medicines that address global health needs, the company says.

Chimerix is advancing programs to address cytomegalovirus (CMV), BK virus, adenovirus, smallpox, human immunodeficiency virus (HIV),hepatitis C virus (HCV), respiratory syncytial virus (RSV) and influenza.

Atlanta’s Omnilink Systems names Kelly Gay CEO, president

Thursday, April 29th, 2010

ATLANTA – Omnilink Systems, which sells end-to-end LBS (location-based services) solutions for the enterprise, consumer and government markets, has named Kelly Gay president and CEO.

Throughout her nearly 25 year career, Gay has led a number of prominent companies across a variety of tech industries, including the role of chairman and CEO of KnowledgeStorm where she led the company from start up to annual sales of $20 million in less than seven years.

She was also vice president of IBM’s North American Media and Entertainment division.

She is a past chairman of the Technology Association of Georgia

Gay serves on various boards of directors including Bank of Atlanta, 1105 Media, ReachForce, and Ashworth College.

Omnilink a software platform for powering location-aware mobile devices and applications.